240 related articles for article (PubMed ID: 30108345)
1. Engineering of Primary Human B cells with CRISPR/Cas9 Targeted Nuclease.
Johnson MJ; Laoharawee K; Lahr WS; Webber BR; Moriarity BS
Sci Rep; 2018 Aug; 8(1):12144. PubMed ID: 30108345
[TBL] [Abstract][Full Text] [Related]
2. All-in-One CRISPR-Cas9/FokI-dCas9 Vector-Mediated Multiplex Genome Engineering in Cultured Cells.
Sakuma T; Sakamoto T; Yamamoto T
Methods Mol Biol; 2017; 1498():41-56. PubMed ID: 27709568
[TBL] [Abstract][Full Text] [Related]
3. Genome Engineering of Primary Human B Cells Using CRISPR/Cas9.
Laoharawee K; Johnson MJ; Lahr WS; Peterson JJ; Webber BR; Moriarity BS
J Vis Exp; 2020 Nov; (165):. PubMed ID: 33226023
[TBL] [Abstract][Full Text] [Related]
4. Electroporation-Based CRISPR/Cas9 Gene Editing Using Cas9 Protein and Chemically Modified sgRNAs.
Laustsen A; Bak RO
Methods Mol Biol; 2019; 1961():127-134. PubMed ID: 30912044
[TBL] [Abstract][Full Text] [Related]
5. Conditional Gene Knockout in Human Cells with Inducible CRISPR/Cas9.
Snijders KE; Cooper JD; Vallier L; Bertero A
Methods Mol Biol; 2019; 1961():185-209. PubMed ID: 30912047
[TBL] [Abstract][Full Text] [Related]
6. Efficient CRISPR/Cas9-Mediated Genome Editing in Mice by Zygote Electroporation of Nuclease.
Qin W; Dion SL; Kutny PM; Zhang Y; Cheng AW; Jillette NL; Malhotra A; Geurts AM; Chen YG; Wang H
Genetics; 2015 Jun; 200(2):423-30. PubMed ID: 25819794
[TBL] [Abstract][Full Text] [Related]
7. Minimal 2'-O-methyl phosphorothioate linkage modification pattern of synthetic guide RNAs for increased stability and efficient CRISPR-Cas9 gene editing avoiding cellular toxicity.
Basila M; Kelley ML; Smith AVB
PLoS One; 2017; 12(11):e0188593. PubMed ID: 29176845
[TBL] [Abstract][Full Text] [Related]
8. Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells.
Hendel A; Bak RO; Clark JT; Kennedy AB; Ryan DE; Roy S; Steinfeld I; Lunstad BD; Kaiser RJ; Wilkens AB; Bacchetta R; Tsalenko A; Dellinger D; Bruhn L; Porteus MH
Nat Biotechnol; 2015 Sep; 33(9):985-989. PubMed ID: 26121415
[TBL] [Abstract][Full Text] [Related]
9. Pea early-browning virus-mediated genome editing via the CRISPR/Cas9 system in Nicotiana benthamiana and Arabidopsis.
Ali Z; Eid A; Ali S; Mahfouz MM
Virus Res; 2018 Jan; 244():333-337. PubMed ID: 29051052
[TBL] [Abstract][Full Text] [Related]
10. CRISPR/Cas9: A tool for immunological research.
Hochheiser K; Kueh AJ; Gebhardt T; Herold MJ
Eur J Immunol; 2018 Apr; 48(4):576-583. PubMed ID: 29415333
[TBL] [Abstract][Full Text] [Related]
11. Construction of a CRISPR-Cas9 System for Pig Genome Targeting.
Su YH; Lin TY; Huang CL; Tu CF; Chuang CK
Anim Biotechnol; 2015; 26(4):279-88. PubMed ID: 26158460
[TBL] [Abstract][Full Text] [Related]
12. A Robust Protocol for CRISPR-Cas9 Gene Editing in Human Suspension Cell Lines.
Wardyn JD; Chan ASY; Jeyasekharan AD
Curr Protoc; 2021 Nov; 1(11):e286. PubMed ID: 34748280
[TBL] [Abstract][Full Text] [Related]
13. CRISPR/Cas9-Mediated Gene Knockout and Knockin Human iPSCs.
Petazzi P; Menéndez P; Sevilla A
Methods Mol Biol; 2022; 2454():559-574. PubMed ID: 33190185
[TBL] [Abstract][Full Text] [Related]
14. Orthogonal gene knockout and activation with a catalytically active Cas9 nuclease.
Dahlman JE; Abudayyeh OO; Joung J; Gootenberg JS; Zhang F; Konermann S
Nat Biotechnol; 2015 Nov; 33(11):1159-61. PubMed ID: 26436575
[TBL] [Abstract][Full Text] [Related]
15. Simple Genome Editing of Rodent Intact Embryos by Electroporation.
Kaneko T; Mashimo T
PLoS One; 2015; 10(11):e0142755. PubMed ID: 26556280
[TBL] [Abstract][Full Text] [Related]
16. Mouse genome engineering via CRISPR-Cas9 for study of immune function.
Pelletier S; Gingras S; Green DR
Immunity; 2015 Jan; 42(1):18-27. PubMed ID: 25607456
[TBL] [Abstract][Full Text] [Related]
17. Disruption of exogenous eGFP gene using RNA-guided endonuclease in bovine transgenic somatic cells.
Choi W; Yum S; Lee S; Lee W; Lee J; Kim S; Koo O; Lee B; Jang G
Zygote; 2015 Dec; 23(6):916-23. PubMed ID: 25424059
[TBL] [Abstract][Full Text] [Related]
18. Rapid and Efficient Gene Deletion by CRISPR/Cas9.
Neldeborg S; Lin L; Stougaard M; Luo Y
Methods Mol Biol; 2019; 1961():233-247. PubMed ID: 30912049
[TBL] [Abstract][Full Text] [Related]
19. CRISPR-Cas9-Mediated Genome Editing and Transcriptional Control in Yarrowia lipolytica.
Schwartz C; Wheeldon I
Methods Mol Biol; 2018; 1772():327-345. PubMed ID: 29754237
[TBL] [Abstract][Full Text] [Related]
20. Targeted Knockout of the Vegfa Gene in the Retina by Subretinal Injection of RNP Complexes Containing Cas9 Protein and Modified sgRNAs.
Holmgaard AB; Askou AL; Jensen EG; Alsing S; Bak RO; Mikkelsen JG; Corydon TJ
Mol Ther; 2021 Jan; 29(1):191-207. PubMed ID: 33022212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
